Therapeutic Use of KASPER and Urine Drug Screening and Testing in Clinical Practice

By UK HealthCare CECentral

Webcast
Oct 31, 2017 - Mar 18, 2025
AMA PRA Category 1 Credit™ : 0.75 +
Free

Interested

Overview

Therapeutic Use of KASPER and Urine Drug Screening and Testing in Clinical Practice is organized by UK HealthCare CECentral.

Release: Oct 31, 2017
Expires: Mar 18, 2025

Needs Statement:
KASPER and UDS/T can be used as therapeutic clinical tools to help monitor for unintended adverse effects of prescribed opioids (and other controlled drugs with known abuse potential and increasing presence in overdose death cases such as the opioids and benzodiazepines) and to help health providers not be unintentional sources of diverted medications. This process can get providers talking more to patients (and their family/friends) about the need for safe storage, diversion, misuse, and substance use disorder that impacts patients and public health.

Objectives:
Upon completion of this educational activity, you will be able to:
• Interpret and verify a KASPER report
• Understand how to have appropriate conversations with patients about unexpected KASPER report results
• Review metabolism of commonly prescribed pain pills that can affect interpretation of urine drug test and give case examples of common misinterpreted results
• Explain the differences between urine screens vs. tests

Additional details will be posted as soon as information is available.

Topic(s)

Prescribe opioids
Prescribing of Controlled Drugs
- Dentist: State Required Topic for Maryland
Prescribing of controlled substances
- Physician: State Required Topic for Alabama, Delaware, Florida, Mississippi, New Mexico, Oklahoma, South Carolina, Tennessee, Utah, Virginia, Vermont and Wyoming
- Dentist: State Required Topic for Connecticut, Florida, South Carolina, West Virginia and Wyoming
KASPER
- Physician: State Required Topic for Kentucky

Credit Info

CME
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Kentucky College of Medicine, Operation UNITE, and Kentucky Office of Drug Control Policy. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

This training has been approved by the KBML as meeting the statutory requirements of HB1.

ACGME Competencies
• Patient care

Other
UK Healthcare CECentral certifies this activity for 0.75 hours of participation.

CPHCE
University of Kentucky College of Public Health certifies that this educational activity was designated for 1.00 hour of Public Health Continuing Education (CPHCE) credit. This course is approved for continuing education by the University of Kentucky College of Public Health.

Total Credit(s)

AMA PRA Category 1 Credit™ : 0.75
Hours : 1
Credits : 0.75
CME : 0.75

Specialties

Research and Clinical Research
Urology

Target Audience

Physician
Dentist
Nursing - RN
Healthcare Professionals

Speaker (s)

1 Speaker(s)

Contact Us

Toll free Number

1(800) 828-2059

support@eMedEvents.com